Pierre Regibeau, Dec 20, 2013
Antitrust concerns about “pay-for-delay” patent settlements are based on two theories of harms, one that stresses the need for courts to review the validity of patents and one that emphasizes the “probabilistic” nature of patent rights. The main weakness of the first theory of harm is that it fails to explain why some forms of patent settlements would be less desirable than others. The “probabilistic” theory of harm raises fundamental questions about the legal obligations of a patent-holder, the type of uncertainty that should be reflected in the probabilistic nature of the patents and whether the theory can be applied to anything but the simplest PFD settlements. This article also discusses the likely effect of a PFD ban on innovation and reviews both the European approach to recent and ongoing PFD cases and the recent Actavis decision of the US Supreme Court.
Featured News
Warren, Banks Call for FTC Investigation of Fire Truck Market Concentration
Jul 21, 2026 by
CPI
Metro Bank Weighs £2 Billion Bid for Aldermore
Jul 21, 2026 by
CPI
EU Antitrust Probe Deepens as Cemex Receives Formal Objections
Jul 21, 2026 by
CPI
Google Settles Russian Antitrust Case, Opens Android to Rival Search Services
Jul 21, 2026 by
CPI
Kentucky Settles Antitrust Claims Against Greystar in RealPage Rent-Setting Case
Jul 21, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes